| Smartinhaler
Technology Overview:
Smartinhaler(TM) devices monitor and report patients' medication usage to their healthcare partners (care giver, parent, payer), and are used in pharmaceutical clinical trials and respiratory disease management applications for chronic obstructive pulmonary disease, asthma and cystic fibrosis. SmartinhalerLive(TM) uses wireless communications technology to provide real time data collection and reporting from drug delivery devices.
MedNest Deliverables:
MedNest has segmented and profiled the market and clinical opportunities for SmartInhaler in the US. Following this "calibration" phase, the segment of Respiratory Clinical Research has been targeted (Value proposition creation, Partnership search) to establish Commercial and Technology Partnerships.
Recent updates:
- August 2009: Smart Track receives FDA 510k
- September 2009: NEXUS6 OEM Wireless (micro-GSM phone) Communication Module is launched
- October 2009: Technology Partnership with Microdose Therapeutix delivers above expectations.
- Looking for financial and clinical partners to run an economic trial and demonstrate outcomes and ROI in the pediatric field.
- Looking for partnerships to create other "wireless" devices.
|
|
